News & Press Releases
Filter by:
Adam Lenain Joins Biocom California Board of Governors
June 04, 2025
Mintz Member Adam Lenain has been named to the Board of Governors of Biocom California, the leading association and advocate for California’s life science sector.
Of Counsel Michelle Capezza was quoted in Fiduciary News discussing the Department of Labor’s recent Compliance Assistance Release, which rescinds its 2022 guidance on cryptocurrency in retirement plans.
Michael Fantozzi, Managing Member of Mintz’s Boston office, was named a 2025 Top Managing Partner by Massachusetts Lawyers Weekly.
Mintz IP Practice Recognized in 2025 IAM Patent 1000
June 02, 2025
Mintz’s Intellectual Property (IP) Practice earned national recognition in the 2025 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners. The guide recognized Mintz with four firm-wide rankings and 15 individual attorney recommendations, including a gold ranking for Michael T. Renaud, who leads Mintz’s IP practice.
Patenting AI/ML Life Sciences and TechBio Innovations – How Much Disclosure Is Sufficient?
June 1, 2025
The Intellectual Property & Technology Law Journal published an article by Member Terri Shieh-Newton, PhD and Associate Hanna Kim about ensuring sufficient disclosure in patent applications for AI/machine learning and TechBio innovations in the life sciences sector.
Pratt's Privacy and Cybersecurity Report published an article by Privacy & Cybersecurity Practice Co-chair Scott Lashway, Special Counsel Matthew MK Stein, Of Counsel Cassandra Paolillo, and Associate Kayla LaRosa examining the differences between the New York legislature's version of Washington's My Health Data Act and the Washington law. The New York Health Information Privacy Act currently awaits Kathy Hochul’s signature.